wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36064908-2C14CD14-103B-42E9-8E4F-29B99111089F
Q36064908-2C14CD14-103B-42E9-8E4F-29B99111089F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36064908-2C14CD14-103B-42E9-8E4F-29B99111089F
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer
P2860
Q36064908-2C14CD14-103B-42E9-8E4F-29B99111089F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36064908-2C14CD14-103B-42E9-8E4F-29B99111089F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8980fd46be9c7db6f884b01876eb7874de567098
P2860
Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study.